Hooper,lundy& Bookman, PC (Obo Roche Diagnostics)

Law firm

Based in DC

🤖

AI Overview

With $410K in lobbying spend across 25 quarterly filings, Hooper,lundy& Bookman, PC (Obo Roche Diagnostics) is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2019 to 2024.

$410K
Total Spend
6
Years Active
1
Firms Hired
1
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2019$70K
2020$80K
2021$80K
2022$80K
2023$60K
2024$40K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Hooper,lundy& Bookman, PC (Obo Roche Diagnostics) disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Science/Technology, Medicare/Medicaid, Budget/Appropriations

FDA regulation of laboratory-developed tests (LDTs).

The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018

H.R. 269-Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

HR 3584-The Laboratory Access for Beneficiaries Act

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.